Evidence map›Paper›PMID 19073624›Full record

ArticleCerebral cortex (New York, N.Y. : 1991)2009

Performance effects of nicotine during selective attention, divided attention, and simple stimulus detection: an fMRI study.

Britta Hahn, Thomas J Ross, Frank A Wolkenberg, Diaa M Shakleya, Marilyn A Huestis, Elliot A Stein

Abstract readControlled Clinical Trial
In one paragraph

Article in Cerebral cortex (New York, N.Y. : 1991), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Short-term nicotine deprivation alters dorsal anterior cingulate glutamate concentration and concomitant cingulate-cortical functional connectivity.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2020
    Trial
  6. Trial
  7. Trial
  8. Trial
  9. Human brain functional network changes associated with enhanced and impaired attentional task performance.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2013
    Trial
  10. Trial
  11. Trial
  12. The effects of nicotine replacement on cognitive brain activity during smoking withdrawal studied with simultaneous fMRI/EEG.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2011
    Trial
  13. Trial
  14. Review
  15. Cholinergic modulation of sensory perception and plasticity.Neuroscience and biobehavioral reviews · 2023
    Review
  16. Article
  17. Neurochemistry of Visual Attention.Frontiers in neuroscience · 2021
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Britta HahnNeuroimaging Research Branch, NIH/National Institute on Drug Abuse-Intramural Research Program (IRP), BiomedicalResearch Center, Baltimore, MD 21224, USA. bhahn@mprc.umaryland.edu
Thomas J Ross
Frank A Wolkenberg
Diaa M Shakleya
Marilyn A Huestis
Elliot A Stein

Funding

Functional and Structural Brain Circuits Underlying SmokingZIADA000573 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI STEIN, ELLIOT A · 2010 to 2021
$19.4M
Brain Imaging of Human Drug AbuseZIADA000470 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI STEIN, ELLIOT A · 2009 to 2021
$15.8M
Brain Imaging of Human Drug AbuseZ01DA000470 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI STEIN, ELLIOT A · 2004 to 2008
$6.6M
Pharmacokinetics And Pharmacodynamics Of Smoked Drugs Of AbuseZIADA000413 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI SCHEIDWEILER, KARL · 2009 to 2016
$6.0M
Smoked Drugs Of Abuse: Pharmacokinetics/PharmacodynamicsZ01DA000413 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI HUESTIS, MARILYN A · 1998 to 2008
$746k
Intramural NIH HHS
6 · The paper itself

Abstract

Attention-enhancing effects of nicotine appear to depend on the nature of the attentional function. Underlying neuroanatomical mechanisms, too, may vary depending on the function modulated. This functional magnetic resonance imaging study recorded blood oxygen level-dependent (BOLD) activity in minimally deprived smokers during tasks of simple stimulus detection, selective attention, or divided attention after single-blind application of a transdermal nicotine (21 mg) or placebo patch. Smokers' performance in the placebo condition was unimpaired as compared with matched nonsmokers. Nicotine reduced reaction time (RT) in the stimulus detection and selective attention but not divided attention condition. Across all task conditions, nicotine reduced activation in frontal, temporal, thalamic, and visual regions and enhanced deactivation in so-called "default" regions. Thalamic effects correlated with RT reduction selectively during stimulus detection. An interaction with task condition was observed in middle and superior frontal gyri, where nicotine reduced activation only during stimulus detection. A visuomotor control experiment provided evidence against nonspecific effects of nicotine. In conclusion, although prefrontal activity partly displayed differential modulation by nicotine, most BOLD effects were identical across tasks, despite differential performance effects, suggesting that common neuronal mechanisms can selectively benefit different attentional functions. Overall, the effects of nicotine may be explained by increased functional efficiency and downregulated task-independent "default" functions.

Indexed as

AdolescentAdultAttentionBrainBrain MappingCuesFemaleGanglionic StimulantsHumansMagnetic Resonance ImagingMaleMiddle AgedNicotinePerceptual MaskingPsychomotor PerformanceSmokingGanglionic StimulantsNicotine

Identifiers

PMID19073624
PMCPMC2733682

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.